While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >
While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >
Catalog #: RVSV-GL-2
$600.00
Third-generation replication-incompetent lentiviral vector expressing the luciferase reporter gene packaged as viral particles which are pseudotyped with VSV-G, which enables transduction of virtually any mammalian cell.
This product is designed as a positive control for pseudovirus infection when performing transduction assays with pseudotyped lentiviral particles targeting specific cell receptors, such as Cellecta's SARS Spike protein pseudotyped lentivirus.
Coming Soon